1. Home
  2. ONCO
  3. ONCO News

Latest Onconetix Inc. (ONCO) News on July 26, 2024

Onconetix Announces Closing of Warrant Exercise for $1.11 Million Gross Proceeds
ONCO

GlobeNewswire

12 days ago

Onconetix Announces Closing of Warrant Exercise for $1.11 Million Gross Proceeds

Onconetix Announces Exercise of Warrants for $1.11 Million Gross Proceeds
ONCO

GlobeNewswire

15 days ago

Onconetix Announces Exercise of Warrants for $1.11 Million Gross Proceeds

ONCO

GlobeNewswire

5 months ago

Onconetix Announces Appointment of Seasoned Biotech Executives Dr. Ajit Singh and Dr. Thomas Meier to Its Board of Directors

CFSB BANCORP, INC. ANNOUNCES FISCAL SECOND QUARTER AND YEAR-TO-DATE 2024 FINANCIAL RESULTS
ONCO

PR Newswire

6 months ago

CFSB BANCORP, INC. ANNOUNCES FISCAL SECOND QUARTER AND YEAR-TO-DATE 2024 FINANCIAL RESULTS

Jet.AI to Participate in A.G.P.’s Virtual Technology Conference
ONCO

GlobeNewswire

6 months ago

Jet.AI to Participate in A.G.P.’s Virtual Technology Conference

BTCS Issues Shareholder Letter Reflecting on 2023 and Outlook for 2024
ONCO

GlobeNewswire

6 months ago

BTCS Issues Shareholder Letter Reflecting on 2023 and Outlook for 2024

Guardforce AI Appoints Yuting Zuo as Chief Financial Officer
ONCO

GlobeNewswire

6 months ago

Guardforce AI Appoints Yuting Zuo as Chief Financial Officer

WidePoint Awarded More than $70.3 Million in IT and Security Services Contracts During Q4 2023
ONCO

ACCESSWIRE

6 months ago

WidePoint Awarded More than $70.3 Million in IT and Security Services Contracts During Q4 2023

Celebrating 20 Years of Cutting-Edge Onboard Broadcasting and Technical Innovation: Vislink and MotoGP™
ONCO

GlobeNewswire

6 months ago

Celebrating 20 Years of Cutting-Edge Onboard Broadcasting and Technical Innovation: Vislink and MotoGP™

Acorda Therapeutics to Regain Global Commercialization Rights to FAMPYRA® by January 2025
ONCO

Business Wire

6 months ago

Acorda Therapeutics to Regain Global Commercialization Rights to FAMPYRA® by January 2025

Precision BioSciences Completes License Deal with TG Therapeutics for Cell Therapy Azer-Cel in Treatment of Autoimmune Diseases
ONCO

Business Wire

7 months ago

Precision BioSciences Completes License Deal with TG Therapeutics for Cell Therapy Azer-Cel in Treatment of Autoimmune Diseases

Origin Agritech Reports Fiscal Year End 2023 Results
ONCO

PR Newswire

7 months ago

Origin Agritech Reports Fiscal Year End 2023 Results

Bionomics to Present at Biotech Showcase™ 2024
ONCO

GlobeNewswire

7 months ago

Bionomics to Present at Biotech Showcase™ 2024

BioCardia Biotherapeutic Delivery and Morph Access Innovations Business Development Update for Shareholders
ONCO

GlobeNewswire

7 months ago

BioCardia Biotherapeutic Delivery and Morph Access Innovations Business Development Update for Shareholders

11 Popular Penny Stocks on Robinhood
ONCO

Insider Monkey

7 months ago

11 Popular Penny Stocks on Robinhood

Rubicon Technologies, Inc. 2023 in Review: A Year of Strategic Growth, Progress Toward Profitability, and Technology Leadership
ONCO

Business Wire

7 months ago

Rubicon Technologies, Inc. 2023 in Review: A Year of Strategic Growth, Progress Toward Profitability, and Technology Leadership

Passage Bio Announces Promising Initial Data From Phase 1/2 Clinical Trial of PBFT02 in FTD-GRN and Updated Strategic Priorities
ONCO

GlobeNewswire

7 months ago

Passage Bio Announces Promising Initial Data From Phase 1/2 Clinical Trial of PBFT02 in FTD-GRN and Updated Strategic Priorities

How Clene CNM-Au8(R) Takes Advantage of Gold Nanocrystals to Target Neurodegenerative Disorders
ONCO

NewMediaWire

7 months ago

How Clene CNM-Au8(R) Takes Advantage of Gold Nanocrystals to Target Neurodegenerative Disorders

Take Care Before Diving Into The Deep End On Concord Medical Services Holdings Limited (NYSE:CCM)
ONCO

Simply Wall St.

7 months ago

Take Care Before Diving Into The Deep End On Concord Medical Services Holdings Limited (NYSE:CCM)

One G. Willi-Food International Insider Raised Stake By 15% In Previous Year
ONCO

Simply Wall St.

7 months ago

One G. Willi-Food International Insider Raised Stake By 15% In Previous Year

Applied DNA Sciences, Inc. (NASDAQ:APDN) Q4 2023 Earnings Call Transcript
ONCO

Insider Monkey

7 months ago

Applied DNA Sciences, Inc. (NASDAQ:APDN) Q4 2023 Earnings Call Transcript

Leading Proxy Advisory Firms, ISS and Glass Lewis, Recommend GT Biopharma Stockholders Vote “FOR” All Proposed Items at the Upcoming Special Meeting of Stockholders
ONCO

GlobeNewswire

8 months ago

Leading Proxy Advisory Firms, ISS and Glass Lewis, Recommend GT Biopharma Stockholders Vote “FOR” All Proposed Items at the Upcoming Special Meeting of Stockholders

Penny Stock Jackpots: 3 High-Stakes Picks With 10-Bagger Potential
ONCO

InvestorPlace

8 months ago

Penny Stock Jackpots: 3 High-Stakes Picks With 10-Bagger Potential

Tiziana Life Sciences to Present at the Webull LIVE! with Corporate Connect: Biotech Investment Webinar
ONCO

GlobeNewswire

8 months ago

Tiziana Life Sciences to Present at the Webull LIVE! with Corporate Connect: Biotech Investment Webinar

SatixFy Receives NYSE American Notice of Non-compliance with Continued Listing Standards
ONCO

Business Wire

8 months ago

SatixFy Receives NYSE American Notice of Non-compliance with Continued Listing Standards

Atara Biotherapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ONCO

Business Wire

8 months ago

Atara Biotherapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Vision Sensing Acquisition Corp. Announces Intention to Extend Period to Consummate Initial Business Combination to January 3, 2024
ONCO

GlobeNewswire

8 months ago

Vision Sensing Acquisition Corp. Announces Intention to Extend Period to Consummate Initial Business Combination to January 3, 2024

Better Choice Research Partner, Aimia Pet HealthCo Inc., Signs Second R&D Partnership Agreement with KGK Science for Development of GLP1 Supplement for Pets
ONCO

GlobeNewswire

8 months ago

Better Choice Research Partner, Aimia Pet HealthCo Inc., Signs Second R&D Partnership Agreement with KGK Science for Development of GLP1 Supplement for Pets

uCloudlink Group Inc. (NASDAQ:UCL) Q3 2023 Earnings Call Transcript
ONCO

Insider Monkey

8 months ago

uCloudlink Group Inc. (NASDAQ:UCL) Q3 2023 Earnings Call Transcript

Alumni Ventures Double Leads With Marin’s Budget Optimization
ONCO

Business Wire

8 months ago

Alumni Ventures Double Leads With Marin’s Budget Optimization

ONCO

Associated Press Finance

8 months ago

Immunic: Q3 Earnings Snapshot

Immunic, Inc. Reports Third Quarter 2023 Financial Results and Provides Corporate Update
ONCO

PR Newswire

8 months ago

Immunic, Inc. Reports Third Quarter 2023 Financial Results and Provides Corporate Update

Sonder Holdings Inc. to Report Third Quarter 2023 Financial Results on November 14, 2023
ONCO

GlobeNewswire

9 months ago

Sonder Holdings Inc. to Report Third Quarter 2023 Financial Results on November 14, 2023

ONCO

Business Wire

9 months ago

MEI Pharma Reports First Quarter Fiscal Year 2024 Results and Operational Highlights

Amicus' (FOLD) Q3 Loss Narrows, Galafold Sales View Updated
ONCO

Zacks

9 months ago

Amicus' (FOLD) Q3 Loss Narrows, Galafold Sales View Updated

NETSOL Technologies Announces Two UK-Based Financial Institutions Go Live with NETSOL’s API-Based Calculation Engine Flex
ONCO

GlobeNewswire

9 months ago

NETSOL Technologies Announces Two UK-Based Financial Institutions Go Live with NETSOL’s API-Based Calculation Engine Flex

American Oncology Network’s Specialty Pharmacy Reports Zero Drug Waste After Value-Based Trial, Secures Unchanged Reimbursement Rate for 2024
ONCO

GlobeNewswire

9 months ago

American Oncology Network’s Specialty Pharmacy Reports Zero Drug Waste After Value-Based Trial, Secures Unchanged Reimbursement Rate for 2024

Share on Social Networks: